PUBLISHER: 360iResearch | PRODUCT CODE: 1608221
PUBLISHER: 360iResearch | PRODUCT CODE: 1608221
Lewy Body Dementia Treatment Market by Drug Type (Antidepressants, Antipsychotic Drugs, Benzodiazepine), Distribution Channel (Online Pharmacies, Retail Pharmacies), Application - Global Forecast 2025-2030
The Lewy Body Dementia Treatment Market was valued at USD 6.12 billion in 2023, expected to reach USD 6.60 billion in 2024, and is projected to grow at a CAGR of 8.54%, to USD 10.87 billion by 2030.
Lewy Body Dementia (LBD) treatment encompasses various therapeutic strategies to manage symptoms of this progressive brain disorder, characterized by abnormal protein deposits affecting cognitive abilities, movement, and mood. The necessity for effective LBD treatments is growing as the aging population increases, necessitating targeted approaches like acetylcholinesterase inhibitors and antipsychotics. These treatments are primarily applied in healthcare settings, including hospitals and specialized dementia care facilities, catering to LBD patients' neurological and psychiatric needs. From a market perspective, the growing awareness of LBD among healthcare professionals and caregivers drives demand for more effective and inclusive therapeutic options. Key growth factors include advances in neurodegenerative disease research, heightened investment in pharmaceutical R&D, and increasing government funding in dementia care initiatives. Potential opportunities lie in developing novel drugs with fewer side effects, personalized medicine approaches tailored to individual genetic profiles, and technological innovations like wearable devices for symptom management. However, the market faces limitations such as the high cost of drug development, significant regulatory hurdles, and the complexity of diagnosing LBD, often leading to misdiagnosis or delayed treatment. Companies can innovate by focusing on integrating artificial intelligence in early diagnosis, enhancing patient monitoring systems, and exploring the potential of combination therapies. There's also a growing scope for telemedicine solutions providing remote diagnosis and management, which can significantly enhance patient and caregiver engagement. As the market evolves, the competition may intensify with an influx of new entrants offering innovative solutions. Despite these challenges, businesses can gain competitive advantages through strategic collaborations, focusing on unmet clinical needs, and maintaining an agile approach to research and development, which can lead to significant breakthroughs in managing LBD.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 6.12 billion |
| Estimated Year [2024] | USD 6.60 billion |
| Forecast Year [2030] | USD 10.87 billion |
| CAGR (%) | 8.54% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lewy Body Dementia Treatment Market
The Lewy Body Dementia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing prevalence of lewy body dementia and absence of concerned drug
- Government initiatives for creating awareness about lewy body dementia
- Favorable reimbursement regulations pertaining to lewy body dementia treatment
- Market Restraints
- High treatment cost along with need of long term care
- Market Opportunities
- Burgeoning number of performed clinical trials for lewy body dementia treatment
- Growing healthcare facilities in countries
- Market Challenges
- Possible adverse effects of drugs
Porter's Five Forces: A Strategic Tool for Navigating the Lewy Body Dementia Treatment Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lewy Body Dementia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Lewy Body Dementia Treatment Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lewy Body Dementia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Lewy Body Dementia Treatment Market
A detailed market share analysis in the Lewy Body Dementia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lewy Body Dementia Treatment Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lewy Body Dementia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Lewy Body Dementia Treatment Market
A strategic analysis of the Lewy Body Dementia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Lewy Body Dementia Treatment Market, highlighting leading vendors and their innovative profiles. These include Axovant Sciences Ltd., Bausch Health Companies Inc., Bayer AG, BioArctic AB, Eisai Co., Ltd., Eli Lilly and Company, Immungenetics AG, Jazz Pharmaceuticals, Inc, Mallinckrodt Pharmaceuticals, Novartis AG, Noven Pharmaceuticals, Inc, Pfizer Inc, Sumitomo Dainippon Pharma Co., Ltd, and Takeda Pharmaceutical Company Ltd..
Market Segmentation & Coverage
This research report categorizes the Lewy Body Dementia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Drug Type, market is studied across Antidepressants, Antipsychotic Drugs, Benzodiazepine, Carbidopa-Levodopa, Cholinesterase Inhibitors, and Modafinil. The Cholinesterase Inhibitors is further studied across Donepezil, Galantamine, and Rivastigmine.
- Based on Distribution Channel, market is studied across Online Pharmacies and Retail Pharmacies.
- Based on Application, market is studied across Alzheimer's Disease, Dementia, and Parkinson's Disease.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of lewy body dementia and absence of concerned drug
- 5.1.1.2. Government initiatives for creating awareness about lewy body dementia
- 5.1.1.3. Favorable reimbursement regulations pertaining to lewy body dementia treatment
- 5.1.2. Restraints
- 5.1.2.1. High treatment cost along with need of long term care
- 5.1.3. Opportunities
- 5.1.3.1. Burgeoning number of performed clinical trials for lewy body dementia treatment
- 5.1.3.2. Growing healthcare facilities in countries
- 5.1.4. Challenges
- 5.1.4.1. Possible adverse effects of drugs
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Lewy Body Dementia Treatment Market, by Drug Type
- 6.1. Introduction
- 6.2. Antidepressants
- 6.3. Antipsychotic Drugs
- 6.4. Benzodiazepine
- 6.5. Carbidopa-Levodopa
- 6.6. Cholinesterase Inhibitors
- 6.6.1. Donepezil
- 6.6.2. Galantamine
- 6.6.3. Rivastigmine
- 6.7. Modafinil
7. Lewy Body Dementia Treatment Market, by Distribution Channel
- 7.1. Introduction
- 7.2. Online Pharmacies
- 7.3. Retail Pharmacies
8. Lewy Body Dementia Treatment Market, by Application
- 8.1. Introduction
- 8.2. Alzheimer's Disease
- 8.3. Dementia
- 8.4. Parkinson's Disease
9. Americas Lewy Body Dementia Treatment Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Lewy Body Dementia Treatment Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Lewy Body Dementia Treatment Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Axovant Sciences Ltd.
- 2. Bausch Health Companies Inc.
- 3. Bayer AG
- 4. BioArctic AB
- 5. Eisai Co., Ltd.
- 6. Eli Lilly and Company
- 7. Immungenetics AG
- 8. Jazz Pharmaceuticals, Inc
- 9. Mallinckrodt Pharmaceuticals
- 10. Novartis AG
- 11. Noven Pharmaceuticals, Inc
- 12. Pfizer Inc
- 13. Sumitomo Dainippon Pharma Co., Ltd
- 14. Takeda Pharmaceutical Company Ltd.
LIST OF FIGURES
- FIGURE 1. LEWY BODY DEMENTIA TREATMENT MARKET RESEARCH PROCESS
- FIGURE 2. LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. LEWY BODY DEMENTIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. LEWY BODY DEMENTIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. LEWY BODY DEMENTIA TREATMENT MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. LEWY BODY DEMENTIA TREATMENT MARKET DYNAMICS
- TABLE 7. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ANTIPSYCHOTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY BENZODIAZEPINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CARBIDOPA-LEVODOPA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DONEPEZIL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY GALANTAMINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY MODAFINIL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 24. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 27. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 28. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 29. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 30. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 31. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 32. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 33. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 34. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 35. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 36. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 37. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 38. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 39. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 40. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 41. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 42. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 43. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 44. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 45. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 46. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 47. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 48. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 49. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 50. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 51. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 52. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 53. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 54. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 55. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 56. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 57. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 58. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 59. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 60. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 61. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 62. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 63. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 64. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 65. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 66. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 67. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 68. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 69. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 70. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 71. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 72. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 73. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 74. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 75. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 76. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 77. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 78. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 79. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 80. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 81. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 82. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 83. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 84. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 85. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 86. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 87. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 88. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 89. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 90. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 91. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 92. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 93. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 94. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 95. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 96. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 97. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 98. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 99. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 100. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 101. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 102. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 103. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 104. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 105. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 106. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 107. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 108. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 109. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 110. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 111. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 112. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 113. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 114. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 115. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 116. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 117. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 118. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 119. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 120. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 121. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 122. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 123. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 124. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 125. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 126. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 127. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 128. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 129. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 130. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 131. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 132. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 133. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 134. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 135. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 136. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 137. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 138. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 139. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 140. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 141. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 142. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 143. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 144. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 145. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 146. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 147. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 148. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 149. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 150. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 151. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 152. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 153. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 154. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 155. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 156. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 157. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 158. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 159. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 160. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 161. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 162. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 163. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 164. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 165. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 166. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 167. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 168. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 169. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 170. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 171. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 172. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 173. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 174. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 175. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 176. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 177. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 178. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 179. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 180. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 181. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 182. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 183. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 184. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 185. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 186. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 187. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 188. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 189. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 190. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
- TABLE 191. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 192. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 193. LEWY BODY DEMENTIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 194. LEWY BODY DEMENTIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
